The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cas Nuclease Market Research Report 2025
Synopsis
The global Cas Nuclease market was valued at US$ 146.5 million in 2023 and is anticipated to reach US$ 821.1 million by 2030, witnessing a CAGR of 27.8% during the forecast period 2024-2030.
The main manufacturers of Cas nuclease include Thermo Fisher Scientific, GenScript and Integrated DNA Technologies, Inc., etc. The top three manufacturers account for about 45% of the share. North America is the largest market with about 44% share, followed by Europe and China with about 35% and 8% of the market. Cas9 is the largest segment with an 85% share. Gene editing cell line construction was the largest application with about 40% share.
This report aims to provide a comprehensive presentation of the global market for Cas Nuclease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cas Nuclease.
Report Scope
The Cas Nuclease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cas Nuclease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cas Nuclease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
GenScript
Integrated DNA Technologies, Inc.
Aldevron
Merck
Horizon Discovery
Agilent
OriGene Technologies, Inc
New England Biolabs
NIPPON GENE CO., LTD.
Novoprotein
Applied Biological Materials Inc. (abm)
Segment by Type
Cas9
Cas12
Cas13
Others
Segment by Application
Gene Editing Cell Line Construction
Animal Models
Bioagriculture
Gene Therapy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cas Nuclease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Cas Nuclease market was valued at US$ 146.5 million in 2023 and is anticipated to reach US$ 821.1 million by 2030, witnessing a CAGR of 27.8% during the forecast period 2024-2030.
The main manufacturers of Cas nuclease include Thermo Fisher Scientific, GenScript and Integrated DNA Technologies, Inc., etc. The top three manufacturers account for about 45% of the share. North America is the largest market with about 44% share, followed by Europe and China with about 35% and 8% of the market. Cas9 is the largest segment with an 85% share. Gene editing cell line construction was the largest application with about 40% share.
This report aims to provide a comprehensive presentation of the global market for Cas Nuclease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cas Nuclease.
Report Scope
The Cas Nuclease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cas Nuclease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cas Nuclease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
GenScript
Integrated DNA Technologies, Inc.
Aldevron
Merck
Horizon Discovery
Agilent
OriGene Technologies, Inc
New England Biolabs
NIPPON GENE CO., LTD.
Novoprotein
Applied Biological Materials Inc. (abm)
Segment by Type
Cas9
Cas12
Cas13
Others
Segment by Application
Gene Editing Cell Line Construction
Animal Models
Bioagriculture
Gene Therapy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cas Nuclease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cas Nuclease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cas9
1.2.3 Cas12
1.2.4 Cas13
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cas Nuclease Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Gene Editing Cell Line Construction
1.3.3 Animal Models
1.3.4 Bioagriculture
1.3.5 Gene Therapy
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cas Nuclease Market Perspective (2019-2030)
2.2 Cas Nuclease Growth Trends by Region
2.2.1 Global Cas Nuclease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cas Nuclease Historic Market Size by Region (2019-2024)
2.2.3 Cas Nuclease Forecasted Market Size by Region (2025-2030)
2.3 Cas Nuclease Market Dynamics
2.3.1 Cas Nuclease Industry Trends
2.3.2 Cas Nuclease Market Drivers
2.3.3 Cas Nuclease Market Challenges
2.3.4 Cas Nuclease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cas Nuclease Players by Revenue
3.1.1 Global Top Cas Nuclease Players by Revenue (2019-2024)
3.1.2 Global Cas Nuclease Revenue Market Share by Players (2019-2024)
3.2 Global Cas Nuclease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cas Nuclease Revenue
3.4 Global Cas Nuclease Market Concentration Ratio
3.4.1 Global Cas Nuclease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cas Nuclease Revenue in 2023
3.5 Cas Nuclease Key Players Head office and Area Served
3.6 Key Players Cas Nuclease Product Solution and Service
3.7 Date of Enter into Cas Nuclease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cas Nuclease Breakdown Data by Type
4.1 Global Cas Nuclease Historic Market Size by Type (2019-2024)
4.2 Global Cas Nuclease Forecasted Market Size by Type (2025-2030)
5 Cas Nuclease Breakdown Data by Application
5.1 Global Cas Nuclease Historic Market Size by Application (2019-2024)
5.2 Global Cas Nuclease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cas Nuclease Market Size (2019-2030)
6.2 North America Cas Nuclease Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cas Nuclease Market Size by Country (2019-2024)
6.4 North America Cas Nuclease Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cas Nuclease Market Size (2019-2030)
7.2 Europe Cas Nuclease Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cas Nuclease Market Size by Country (2019-2024)
7.4 Europe Cas Nuclease Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cas Nuclease Market Size (2019-2030)
8.2 Asia-Pacific Cas Nuclease Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cas Nuclease Market Size by Region (2019-2024)
8.4 Asia-Pacific Cas Nuclease Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cas Nuclease Market Size (2019-2030)
9.2 Latin America Cas Nuclease Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cas Nuclease Market Size by Country (2019-2024)
9.4 Latin America Cas Nuclease Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cas Nuclease Market Size (2019-2030)
10.2 Middle East & Africa Cas Nuclease Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cas Nuclease Market Size by Country (2019-2024)
10.4 Middle East & Africa Cas Nuclease Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cas Nuclease Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cas Nuclease Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 GenScript
11.2.1 GenScript Company Detail
11.2.2 GenScript Business Overview
11.2.3 GenScript Cas Nuclease Introduction
11.2.4 GenScript Revenue in Cas Nuclease Business (2019-2024)
11.2.5 GenScript Recent Development
11.3 Integrated DNA Technologies, Inc.
11.3.1 Integrated DNA Technologies, Inc. Company Detail
11.3.2 Integrated DNA Technologies, Inc. Business Overview
11.3.3 Integrated DNA Technologies, Inc. Cas Nuclease Introduction
11.3.4 Integrated DNA Technologies, Inc. Revenue in Cas Nuclease Business (2019-2024)
11.3.5 Integrated DNA Technologies, Inc. Recent Development
11.4 Aldevron
11.4.1 Aldevron Company Detail
11.4.2 Aldevron Business Overview
11.4.3 Aldevron Cas Nuclease Introduction
11.4.4 Aldevron Revenue in Cas Nuclease Business (2019-2024)
11.4.5 Aldevron Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Cas Nuclease Introduction
11.5.4 Merck Revenue in Cas Nuclease Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Horizon Discovery
11.6.1 Horizon Discovery Company Detail
11.6.2 Horizon Discovery Business Overview
11.6.3 Horizon Discovery Cas Nuclease Introduction
11.6.4 Horizon Discovery Revenue in Cas Nuclease Business (2019-2024)
11.6.5 Horizon Discovery Recent Development
11.7 Agilent
11.7.1 Agilent Company Detail
11.7.2 Agilent Business Overview
11.7.3 Agilent Cas Nuclease Introduction
11.7.4 Agilent Revenue in Cas Nuclease Business (2019-2024)
11.7.5 Agilent Recent Development
11.8 OriGene Technologies, Inc
11.8.1 OriGene Technologies, Inc Company Detail
11.8.2 OriGene Technologies, Inc Business Overview
11.8.3 OriGene Technologies, Inc Cas Nuclease Introduction
11.8.4 OriGene Technologies, Inc Revenue in Cas Nuclease Business (2019-2024)
11.8.5 OriGene Technologies, Inc Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Detail
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Cas Nuclease Introduction
11.9.4 New England Biolabs Revenue in Cas Nuclease Business (2019-2024)
11.9.5 New England Biolabs Recent Development
11.10 NIPPON GENE CO., LTD.
11.10.1 NIPPON GENE CO., LTD. Company Detail
11.10.2 NIPPON GENE CO., LTD. Business Overview
11.10.3 NIPPON GENE CO., LTD. Cas Nuclease Introduction
11.10.4 NIPPON GENE CO., LTD. Revenue in Cas Nuclease Business (2019-2024)
11.10.5 NIPPON GENE CO., LTD. Recent Development
11.11 Novoprotein
11.11.1 Novoprotein Company Detail
11.11.2 Novoprotein Business Overview
11.11.3 Novoprotein Cas Nuclease Introduction
11.11.4 Novoprotein Revenue in Cas Nuclease Business (2019-2024)
11.11.5 Novoprotein Recent Development
11.12 Applied Biological Materials Inc. (abm)
11.12.1 Applied Biological Materials Inc. (abm) Company Detail
11.12.2 Applied Biological Materials Inc. (abm) Business Overview
11.12.3 Applied Biological Materials Inc. (abm) Cas Nuclease Introduction
11.12.4 Applied Biological Materials Inc. (abm) Revenue in Cas Nuclease Business (2019-2024)
11.12.5 Applied Biological Materials Inc. (abm) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
